BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jonges LE, Nagelkerke JF, Ensink NG, van der Velde EA, Tollenaar RA, Fleuren GJ, van de Velde CJ, Morreau H, Kuppen PJ. Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest. 2001;81:681-688. [PMID: 11351040 DOI: 10.1038/labinvest.3780277] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Konstantinidou AE, Givalos N, Gakiopoulou H, Korkolopoulou P, Kotsiakis X, Boviatsis E, Agrogiannis G, Mahera H, Patsouris E. Caspase-3 immunohistochemical expression is a marker of apoptosis, increased grade and early recurrence in intracranial meningiomas. Apoptosis 2007;12:695-705. [PMID: 17143787 DOI: 10.1007/s10495-006-0001-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
2 Abdullah M, Syam AF, Meilany S, Laksono B, Prabu OG, Bekti HS, Indrawati L, Makmun D. The Value of Caspase-3 after the Application of Annona muricata Leaf Extract in COLO-205 Colorectal Cancer Cell Line. Gastroenterol Res Pract 2017;2017:4357165. [PMID: 28487731 DOI: 10.1155/2017/4357165] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
3 Zhou M, Liu X, Li Z, Huang Q, Li F, Li CY. Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells. Int J Cancer 2018;143:921-30. [PMID: 29524226 DOI: 10.1002/ijc.31374] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 19.7] [Reference Citation Analysis]
4 Sadowska A, Car H, Pryczynicz A, Guzińska-Ustymowicz K, Kowal KW, Cepowicz D, Kędra B. Expression of apoptotic proteins in human colorectal cancer and metastatic lymph nodes. Pathol Res Pract 2014;210:576-81. [PMID: 24939147 DOI: 10.1016/j.prp.2014.04.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
5 Yoo Jy, Kim CH, Song SH, Shim BY, Jeong YJ, Ahn MI, Kim S, Cho DG, Jo MS, Cho KD, Cho HJ, Kang SJ, Kim HK. Expression of caspase-3 and c-myc in non-small cell lung cancer. Cancer Res Treat 2004;36:303-7. [PMID: 20368820 DOI: 10.4143/crt.2004.36.5.303] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
6 Salamanna F, Borsari V, Pagani S, Brodano GB, Gasbarrini A, Fini M. Development and characterization of a novel human 3D model of bone metastasis from breast carcinoma in vitro cultured. Bone 2021;143:115773. [PMID: 33249322 DOI: 10.1016/j.bone.2020.115773] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li J, Wang Q, Wang Z, Cui N, Yang B, Niu W, Kuang H. Tetrandrine inhibits colon carcinoma HT-29 cells growth via the Bcl-2/Caspase 3/PARP pathway and G1/S phase. Biosci Rep 2019;39:BSR20182109. [PMID: 31040202 DOI: 10.1042/BSR20182109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
8 van der Meer P, Lipsic E, Henning RH, de Boer RA, Suurmeijer AJ, van Veldhuisen DJ, van Gilst WH. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury. Eur J Heart Fail 2004;6:853-9. [PMID: 15556046 DOI: 10.1016/j.ejheart.2004.03.012] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
9 Yoo NJ, Kim HS, Kim SY, Park WS, Kim SH, Lee JY, Lee SH. Stomach cancer highly expresses both initiator and effector caspases; an immunohistochemical study. APMIS 2002;110:825-32. [PMID: 12588423 DOI: 10.1034/j.1600-0463.2002.1101109.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
10 Reimers MS, Zeestraten EC, Kuppen PJ, Liefers GJ, van de Velde CJ. Biomarkers in precision therapy in colorectal cancer. Gastroenterol Rep (Oxf) 2013;1:166-83. [PMID: 24759962 DOI: 10.1093/gastro/got022] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 8.0] [Reference Citation Analysis]
11 Karatepe O, Acet E, Battal M, Adas G, Kemik A, Altiok M, Kamali G, Koculu S, Catay A, Kamali S. Effects of glutamine and curcumin on bacterial translocation in jaundiced rats. World J Gastroenterol. 2010;16:4313-4320. [PMID: 20818815 DOI: 10.3748/wjg.v16.34.4313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Zeestraten EC, Benard A, Reimers MS, Schouten PC, Liefers GJ, van de Velde CJ, Kuppen PJ. The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry. Biomark Cancer 2013;5:13-29. [PMID: 24179395 DOI: 10.4137/BIC.S11475] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
13 Redondo M, Abitei C, Téllez T, Fúnez R, Pereda T, Rodrigo I, Betancourt AM, García-Aranda M, Rueda A, Martínez García RC, Morales Suarez-Varela MM, Zabalza I, Sánchez Del Charco M, Borrero Martín JJ, García Del Moral R, Escobar A, Quintana J, Rivas-Ruiz F; REDISSEC-CARESS/CCR group. Clinical-pathological characteristics and short-term follow-up associated with proliferation, apoptosis and angiogenesis in a prospective cohort of patients with colorectal tumours. Tumour Biol 2019;42:1010428319835684. [PMID: 30957671 DOI: 10.1177/1010428319835684] [Reference Citation Analysis]
14 Celik A, Ergun E, Koksal N, Celik AS, Altinli E, Uzun MA, Eroglu E, Kemik A. Effects of montelukast on the healing of ischemic colon anastomoses. Am J Surg. 2013;206:502-508. [PMID: 23809995 DOI: 10.1016/j.amjsurg.2013.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
15 Rupa JD, de Bruïne AP, Gerbers AJ, Leers MPG, Nap M, Kessels AGH, Schutte B, Arends JW. Simultaneous detection of apoptosis and proliferation in colorectal carcinoma by multiparameter flow cytometry allows separation of high and low-turnover tumors with distinct clinical outcome: Multiparameter Flow Cytometry. Cancer 2003;97:2404-11. [DOI: 10.1002/cncr.11366] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
16 Liu B, Saber A, Haisma HJ. CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment. Drug Discov Today 2019;24:955-70. [PMID: 30849442 DOI: 10.1016/j.drudis.2019.02.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
17 Koelink PJ, Sier CF, Hommes DW, Lamers CB, Verspaget HW. Clinical significance of stromal apoptosis in colorectal cancer. Br J Cancer 2009;101:765-73. [PMID: 19654576 DOI: 10.1038/sj.bjc.6605220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
18 Menon AG, Janssen-van Rhijn CM, Morreau H, Putter H, Tollenaar RA, van de Velde CJ, Fleuren GJ, Kuppen PJ. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest. 2004;84:493-501. [PMID: 14968119 DOI: 10.1038/labinvest.3700055] [Cited by in Crossref: 161] [Cited by in F6Publishing: 145] [Article Influence: 9.5] [Reference Citation Analysis]
19 Miyatake T, Tringler B, Liu W, Liu SH, Papkoff J, Enomoto T, Torkko KC, Dehn DL, Swisher A, Shroyer KR. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration. Gynecol Oncol. 2007;106:119-127. [PMID: 17509674 DOI: 10.1016/j.ygyno.2007.03.039] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
20 Alcaide J, Funez R, Rueda A, Perez-Ruiz E, Pereda T, Rodrigo I, Coveñas R, Muñoz M, Redondo M. The role and prognostic value of apoptosis in colorectal carcinoma. BMC Clin Pathol 2013;13:24. [PMID: 24106912 DOI: 10.1186/1472-6890-13-24] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
21 Doger FK, Meteoglu I, Tuncyurek P, Okyay P, Cevikel H. Does the EGFR and VEGF expression predict the prognosis in colon cancer? Eur Surg Res. 2006;38:540-544. [PMID: 17085940 DOI: 10.1159/000096774] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
22 Hazelbag S, Gorter A, Kenter GG, van den Broek L, Fleuren G. Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer. Hum Pathol 2002;33:1193-9. [PMID: 12514788 DOI: 10.1053/hupa.2002.130109] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
23 de Heer P, Sandel MH, Guertens G, de Boeck G, Koudijs MM, Nagelkerke JF, Junggeburt JM, de Bruijn EA, van de Velde CJ, Kuppen PJ. Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer. Cancer Chemother Pharmacol. 2008;62:811-819. [PMID: 18247029 DOI: 10.1007/s00280-007-0668-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
24 Shunyakov L, Ryan CK, Sahasrabudhe DM, Khorana AA. The influence of host response on colorectal cancer prognosis. Clin Colorectal Cancer 2004;4:38-45. [PMID: 15207019 DOI: 10.3816/ccc.2004.n.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
25 Mirzayans R, Andrais B, Murray D. Viability Assessment Following Anticancer Treatment Requires Single-Cell Visualization. Cancers (Basel) 2018;10:E255. [PMID: 30071623 DOI: 10.3390/cancers10080255] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
26 Wang J, El-Masry N, Talbot I, Tomlinson I, Alison MR, El-Bahrawy M. Expression Profiling of Proliferation and Apoptotic Markers along the Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis Patients. Gastroenterol Res Pract 2013;2013:107534. [PMID: 23476634 DOI: 10.1155/2013/107534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Menon AG, Fleuren GJ, Alphenaar EA, Jonges LE, Janssen van Rhijn CM, Ensink NG, Putter H, Tollenaar RAEM, van de Velde CJH, Kuppen PJK. A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer. Cancer Immunol Immunother 2003;52:121-6. [DOI: 10.1007/s00262-002-0363-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
28 Kawamoto S, Kamesaki T, Masutani R, Kitao A, Hatanaka K, Imakita M, Tamaki T, Takubo T. Ectopic expression of band 3 anion transport protein in colorectal cancer revealed in an autoimmune hemolytic anemia patient. Human Pathology 2019;83:193-8. [DOI: 10.1016/j.humpath.2018.07.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Fassan M, Cui R, Gasparini P, Mescoli C, Guzzardo V, Vicentini C, Munari G, Loupakis F, Lonardi S, Braconi C, Scarpa M, D'Angelo E, Pucciarelli S, Angriman I, Agostini M, D'Incá R, Farinati F, Gafà R, Lanza G, Frankel WL, Croce CM, Valeri N, Rugge M. miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis. Transl Oncol 2019;12:282-91. [PMID: 30448733 DOI: 10.1016/j.tranon.2018.10.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
30 Karatepe O, Acet E, Battal M, Adas G, Kemik A, Altiok M, Kamali G, Koculu S, Cagatay A, Kamali S, Karahan S. Effects of glutamine and curcumin on bacterial translocation in jaundiced rats. World J Gastroenterol 2010; 16(34): 4313-4320 [PMID: 20818815 DOI: 10.3748/wjg.v16.i34.4313] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
31 Amptoulach S, Lazaris AC, Giannopoulou I, Kavantzas N, Patsouris E, Tsavaris N. Expression of caspase-3 predicts prognosis in advanced noncardia gastric cancer. Med Oncol 2015;32:416. [PMID: 25476481 DOI: 10.1007/s12032-014-0416-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ponnelle T, Chapusot C, Martin L, Bouvier AM, Plenchette S, Faivre J, Solary E, Piard F. Cellular localisation of survivin: impact on the prognosis in colorectal cancer. J Cancer Res Clin Oncol. 2005;131:504-510. [PMID: 15902487 DOI: 10.1007/s00432-005-0682-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
33 Noble P, Vyas M, Al-Attar A, Durrant S, Scholefield J, Durrant L. High levels of cleaved caspase-3 in colorectal tumour stroma predict good survival. Br J Cancer 2013;108:2097-105. [PMID: 23591201 DOI: 10.1038/bjc.2013.166] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
34 Woenckhaus C, Giebel J, Failing K, Fenic I, Dittberner T, Poetsch M. Expression of AP-2?, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression? J Pathol 2003;201:278-87. [DOI: 10.1002/path.1424] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
35 Luo H, Yu S, Li T. Differential expression of apoptosis-related proteins in various cellular components of ameloblastomas. International Journal of Oral and Maxillofacial Surgery 2006;35:750-5. [DOI: 10.1016/j.ijom.2006.03.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
36 Ponnelle T, Chapusot C, Martin L, Bonithon-Kopp C, Bouvier AM, Plenchette S, Rageot D, Faivre J, Solary E, Piard F. Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosis. Pathol Res Pract. 2003;199:723-731. [PMID: 14708638 DOI: 10.1078/0344-0338-00488] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
37 Karatepe HO, Kilincaslan H, Berber M, Ozen A, Saricoban HE, Ustek D, Kemik AS, Adas M, Bakar F. The effect of vascular endothelial growth factor overexpression in experimental necrotizing enterocolitis. Pediatr Surg Int 2014;30:327-32. [DOI: 10.1007/s00383-013-3460-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
38 Ilhan M, Akkol EK, Taştan H, Dereli FTG, Tümen I. Efficacy of Pyrus elaeagnifolia subsp. elaeagnifolia in acetic acid–induced colitis model. Open Chemistry 2019;17:13-22. [DOI: 10.1515/chem-2019-0002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 de Oca J, Azuara D, Sanchez-santos R, Navarro M, Capella G, Moreno V, Sola A, Hotter G, Biondo S, Osorio A, Martí-ragué J, Rafecas A. Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer. Int J Colorectal Dis 2008;23:21-7. [DOI: 10.1007/s00384-007-0362-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
40 Jain R, Austin Pickens C, Fenton JI. The role of the lipidome in obesity-mediated colon cancer risk. J Nutr Biochem 2018;59:1-9. [PMID: 29605789 DOI: 10.1016/j.jnutbio.2018.02.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
41 Srinivasan H, Allory Y, Sill M, Vordos D, Alhamdani MSS, Radvanyi F, Hoheisel JD, Schröder C. Prediction of recurrence of non muscle-invasive bladder cancer by means of a protein signature identified by antibody microarray analyses. Proteomics 2014;14:1333-42. [DOI: 10.1002/pmic.201300320] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
42 Küpeli Akkol E, Gürağaç Dereli FT, Taştan H, Sobarzo-Sánchez E, Khan H. Effect of Sorbus domestica and its active constituents in an experimental model of colitis rats induced by acetic acid. J Ethnopharmacol 2020;251:112521. [PMID: 31883473 DOI: 10.1016/j.jep.2019.112521] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
43 Marijnen CA, Nagtegaal ID, Mulder-stapel AA, Schrier PI, van de Velde CJ, van Krieken JJ, Peltenburg LT. High intrinsic apoptosis, but not radiation-induced apoptosis, predicts better survival in rectal carcinoma patients. International Journal of Radiation Oncology*Biology*Physics 2003;57:434-43. [DOI: 10.1016/s0360-3016(03)00580-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
44 Wang CH, Yang JM, Guo YB, Shen J, Pei XH. Anticancer Activity of Tetrandrine by Inducing Apoptosis in Human Breast Cancer Cell Line MDA-MB-231 In Vivo. Evid Based Complement Alternat Med 2020;2020:6823520. [PMID: 32714412 DOI: 10.1155/2020/6823520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Karatepe O, Altiok M, Battal M, Kamali G, Kemik A, Aydin T, Karahan S. The effect of progesterone in the prevention of the chemically induced experimental colitis in rats. Acta Cir Bras 2012;27:23-9. [PMID: 22159435 DOI: 10.1590/s0102-86502012000100005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
46 Rishi AK, Zhang X, Wali A. Targeting of Apoptosis Signaling Pathways and Their Mediators for Cancer Therapy. In: Lu Y, Mahato RI, editors. Pharmaceutical Perspectives of Cancer Therapeutics. New York: Springer US; 2009. pp. 149-88. [DOI: 10.1007/978-1-4419-0131-6_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
47 Kunac N, Šundov Ž, Vilović K. Apoptosis as a Prognostic Factor in Colorectal Carcinoma: Comparison of TUNEL Method and Immunohistochemical Expression of Caspase-3. Appl Immunohistochem Mol Morphol 2019;27:e22-7. [PMID: 29489504 DOI: 10.1097/PAI.0000000000000623] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
48 Parfitt JR, Driman DK. Survivin and hedgehog protein expression in serrated colorectal polyps: an immunohistochemical study. Hum Pathol 2007;38:710-7. [PMID: 17391730 DOI: 10.1016/j.humpath.2006.12.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
49 Reimers MS, Zeestraten EC, van Alphen TC, Dekker JW, Putter H, Saadatmand S, Liefers GJ, van de Velde CJ, Kuppen PJ. Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarray. Int J Colorectal Dis 2014;29:1043-52. [PMID: 24950792 DOI: 10.1007/s00384-014-1930-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
50 Ozden SA, Ozyurt H, Ozgen Z, Kilinc O, Oncel M, Gul AE, Karadayi N, Serakinci N, Kan B, Orun O. Prognostic role of sensitive-to-apoptosis gene expression in rectal cancer. World J Gastroenterol 2011; 17(44): 4905-4910 [PMID: 22171132 DOI: 10.3748/wjg.v17.i44.4905] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
51 Küpeli Akkol E, Ilhan M, Karpuz B, Taştan H, Sobarzo-Sánchez E, Khan H. Beneficial effects of Ajuga chamaepitys (L.) Schreber subsp. chia (Schreber) and its iridoids on the colitis model: Histopathological and biochemical evidence. Food Chem Toxicol 2020;144:111589. [PMID: 32726593 DOI: 10.1016/j.fct.2020.111589] [Reference Citation Analysis]
52 Mirzayans R, Murray D. Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease Recurrence. Int J Mol Sci 2020;21:E1308. [PMID: 32075223 DOI: 10.3390/ijms21041308] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
53 Chaput N, Svrcek M, Aupérin A, Locher C, Drusch F, Malka D, Taïeb J, Goéré D, Ducreux M, Boige V. Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer. Br J Cancer 2013;109:1013-22. [PMID: 23868006 DOI: 10.1038/bjc.2013.362] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]